Vesicular monoamine transporter inhibitors versus placebo for antipsychotic‐induced tardive dyskinesia
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To report the absolute effects of VMAT2 drugs for people with antipsychotic‐induced tardive dyskinesia.